Septerna

Septerna is a biotechnology company dedicated to the discovery and development of novel small-molecule drugs targeting G protein-coupled receptors (GPCRs). The company's Native Complex™ platform recapitulates the native structure, function, and dynamics of GPCRs outside the cellular environment, offering new technology for the first time to enable industrial-scale drug discovery across the entire GPCR target class. Septerna has a range of emerging GPCR-targeted small-molecule drug discovery programs, as well as the growth potential to address many GPCRs that have been undruggable and untapped to date.